ClinicalTrials.gg
Enrolling by invitationNCT06910228Updated Oct 27, 2025

Changes in Cerebral Oxygenation Related to Intraoperative Position Changes

An observational study in Scoliosis Patients, sponsored by Joseph D. Tobias. Enrolling by invitation at 1 site in United States. Open to participants aged 10 Years to 21 Years. Per ClinicalTrials.gov, last updated 2025-10-27.

Sponsored by Joseph D. Tobias · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
10 Years to 21 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 153 studies in Scoliosis with a site in United States — 42 open to participants now, 51 under way, 2 of them phase 3. Scoliosis · United States.

Planned enrollment
39th of 62
50 · median 100
Started
2025
with 8 others
Observational
62 of 153
21 open now
Primary completion
2026-12
later than 14 of 50 live
Registered
145th of 153
by date

Among the 153 studies in Scoliosis with a site in United States, this one is the 39th largest by planned enrollment of the 62 observational ones that give a count, is one of 9 that started in 2025, is one of 62 observational ones, reaches primary completion later than 14 of the 50 other live ones, and was the 145th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

42 of the 153 studies in Scoliosis with a site in United States are open now. Recruiting first, the newest first:

37 more — sign in →

All 42 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 10 Years to 21 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 153 studies in Scoliosis with a site in United States, or all of them as a file.
02

Study summary

This is a prospective, observational study. This study will assess the effect of temporary changes in body position (supine, head of bed elevated 30 degrees, head of bed elevated 60 degrees) in anesthetized patients. Tissue oxygenation will be assessed non-invasively using near infrared spectroscopy (NIRS) by a device that is used in our operating rooms and the ICU setting to assess cerebral and tissue oxygenation.

03

Conditions studied

  • Scoliosis Patients

Browse trials for

04

Who can participate

Ages eligible
10 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients having surgery at Nationwide Children's Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients 10-21 years of age undergoing posterior spinal fusion, requiring neurophysiologic monitoring and an arterial cannula

Exclusion criteria

Exclusion Criteria:

  • Patients in whom an arterial cannula is not indicated for the surgical procedure
  • Patients with comorbid conditions that may impact cerebral blood flow, cerebral perfusion or place them at risk for cerebral hypoperfusion
  • Patients in whom an invasive arterial cannula cannot be placed
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Interventions

  • DeviceNear infrared spectroscopy (NIRS)

    A non-invasive technique that uses light to assess brain function and tissue oxygenation.

06

What researchers measure

Primary outcomes

  1. Change in cerebral oxygenation at 30 degrees

    Moving the head of the bed to 30 degrees and comparing cerebral oxygen levels to levels when patient was lying flat.

    Time frame: 5-10 minutes after start of study

  2. Change in cerebral oxygenation at 60 degrees

    Moving the head of the bed to 60 degrees and comparing cerebral oxygen levels to levels when patient was lying flat.

    Time frame: 10-15 minutes after start of study

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Dec 2026, 15 months after the start.

Of 94 non-industry observational studies under Scoliosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 99. This study's planned 15 months is below that.

Counting every sponsor, half of 106 studies reached it within 36 months; a quarter within 9 and three quarters within 92.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2025
First posted
Apr 4, 2025
StartActual
Sep 8, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Oct 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06910228
Lead sponsor
Joseph D. Tobias
Responsible party
Joseph D. Tobias (Chief - Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital) — Sponsor-investigator
First posted
Apr 4, 2025
Start date
Sep 8, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 27, 2025

Study contacts

Joseph Tobias, MD
principal investigator · Nationwide Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion